Continuous exposure to dizocilpine facilitates escalation of cocaine consumption in male Sprague-Dawley rats

Drug and Alcohol Dependence

Volumn 134, Issue 1, 2014, Pages 38-43

  Allen, Richard M ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Cocaine; Dizocilpine; Escalation; NMDA; Self administration

Indexed keywords

COCAINE; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; COCAINE DEPENDENCE; CONTROLLED STUDY; EXPOSURE; INTRAVENOUS CATHETER; MALE; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT; REINFORCEMENT; SPRAGUE DAWLEY RAT;

RATTUS;

COCAINE; DIZOCILPINE; ESCALATION; NMDA; SELF-ADMINISTRATION;

ANIMALS; BEHAVIOR, ADDICTIVE; COCAINE; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SELF ADMINISTRATION;

EID: 84890221707     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2013.09.005     Document Type: Article

References (39)

1. Ahmed S.H., Koob G.F. Transition from moderate to excessive drug intake: change in hedonic set point. Science 1998, 282:298-300.
2. Ahmed S.H., Kenny P.J., Koob G.F., Markou A. Neurobiological evidence for hedonic allostasis associated with escalating cocaine use. Nat. Neurosci. 2002, 5:625-626.
3. Ahmed S.H., Lin D., Koob G.F., Parsons L.H. Escalation of cocaine self-administration does not depend on altered cocaine-induced nucleus accumbens dopamine levels. J. Neurochem. 2003, 86:102-113.
4. Allen R.M., Carelli R.M., Dykstra L.A., Suchey T.L., Everett C.V. Effects of the competitive N-methyl-d-aspartate receptor antagonist, LY235959 [(-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid], on responding for cocaine under both fixed and progressive ratio schedules of reinforcement. J. Pharmacol. Exp. Ther. 2005, 315:449-457.
5. Allen R.M., Dykstra L.A., Carelli R.M. Continuous exposure to the competitive N-methyl-d-aspartate receptor antagonist, LY235959, facilitates escalation of cocaine consumption in Sprague-Dawley rats. Psychopharmacology 2007, 191:341-351.
6. Allen R.M., Uban K.A., Atwood E.M., Albeck D.S., Yamamoto D.J. Continuous intracerebroventricular infusion of the competitive NMDA receptor antagonist, LY235959, facilitates escalation of cocaine self-administration and increases break point for cocaine in Sprague-Dawley rats. Pharmacol. Biochem. Behav. 2007, 88:82-88.
7. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Association, Washington, DC. 4th ed.
8. Barrett A.C., Miller J.R., Dohrmann J.M., Caine S.B. Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats. Neuropharmacology 2004, 47(Suppl. 1):256-273.
9. Beardsley P.M., Balster R.L. Behavioral dependence upon phencyclidine and ketamine in the rat. J. Pharmacol. Exp. Ther. 1987, 242:203-211.
10. Ben-Shahar O., Moscarello J.M., Ettenberg A. One hour, but not six hours, of daily access to cocaine results in elevated levels of the dopamine transporter. Brain Res. 2006, 1095:148-153.
11. Ben-Shahar O., Keeley P., Cook M., Brake W., Joyce M., Nyffeler M., Heston R., Ettenberg A. Changes in levels of D1, D2, or NMDA receptors during withdrawal from brief or extended daily access to IV cocaine. Brain Res. 2007, 1131:220-228.
12. Bespalov A.Y., Balster R.L., Beardsley P.M. N-methyl-d-aspartate receptor antagonists and the development of tolerance to the discriminative stimulus effects of morphine in rats. J. Pharmacol. Exp. Ther. 1999, 290:20-27.
13. Briand L.A., Flagel S.B., Garcia-Fuster M.J., Watson S.J., Akil H., Sarter M., Robinson T.E. Persistent alterations in cognitive function and prefrontal dopamine D2 receptors following extended, but not limited, access to self-administered cocaine. Neuropsychopharmacology 2008, 33:2969-2980.
14. Caine S.B., Negus S.S., Mello N.K., Bergman J. Effects of dopamine D(1-like) and D(2-like) agonists in rats that self-administer cocaine. J. Pharmacol. Exp. Ther. 1999, 291:353-360.
15. Cervo L., Samanin R. Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference. Brain Res. 1995, 673:242-250.
16. De Montis M.G., Gambarana C., Ghiglieri O., Tagliamonte A. Reversal of stable behavioural modifications through NMDA receptor inhibition in rats. Behav. Pharmacol. 1995, 6:562-567.
17. Fitch T.E., Roberts D.C. The effects of dose and access restrictions on the periodicity of cocaine self-administration in the rat. Drug Alcohol. Depend. 1993, 33:119-128.
18. Gambarana C., Ghiglieri O., Montis M.G., Tagliamonte A. Under continuous dizocilpine infusion an N-methyl-d-aspartate receptor independent form of cocaine sensitization develops in rats. Behav. Pharmacol. 1998, 9:61-68.
19. Gawin F.H. Cocaine addiction: psychology and neurophysiology. Science 1991, 251:1580-1586.
20. Hyytiä P., Bäckström P., Liljequist S. Site-specific NMDA receptor antagonists produce differential effects on cocaine self-administration in rats. Eur. J. Pharmacol. 1999, 378:9-16.
21. Karler R., Calder L.D., Chaudhry I.A., Turkanis S.A. Blockade of reverse tolerance to cocaine and amphetamine by MK-801. Life Sci. 1989, 45:599-606.
22. Kasanetz F., Deroche-Gamonet V., Berson N., Balado E., Lafourcade M., Manzoni O., Piazza P.V. Transition to addiction is associated with a persistent impairment in synaptic plasticity. Science 2010, 328:1709-1712.
23. Li Y., Hu X.T., Berney T.G., Vartanian A.J., Stine C.D., Wolf M.E., White F.J. Both glutamate receptor antagonists and prefrontal cortex lesions prevent induction of cocaine sensitization and associated neuroadaptations. Synapse 1999, 34:169-180.
24. Li Y., White F.J., Wolf M.E. Pharmacological reversal of behavioral and cellular indices of cocaine sensitization in the rat. Psychopharmacology 2000, 151:175-183.
25. Liu Y., Roberts D.C.S., Morgan D. Effects of extended access self-administration and deprivation on break points maintained by cocaine in rats. Psychopharmacology 2005, 179:644-651.
26. Mandt B.H., Gomez E., Johnston N.L., Zahniser N.R., Allen R.M. Cocaine dose and self-administration history, but not initial cocaine locomotor responsiveness, affects sensitization to the motivational effects of cocaine in rats. J. Pharmacol. Exp. Ther. 2012, 342:214-221.
27. Mantsch J.R., Ho A., Schlussman S.D., Kreek M.J. Predictable individual differences in the initiation of cocaine self-administration by rats under extended-access conditions are dose-dependent. Psychopharmacology 2001, 157:31-39.
28. Oh S., Kim Y.H., Hann H.J., Lee H.L., Choi H.S., Kim H.S., Ho I.K. Modulation of the levels of NMDA receptor subunit mRNA and the bindings of [3H]MK-801 in rat brain by chronic infusion of subtoxic dose of MK-801. Neurochem. Res. 2001, 26:559-565.
29. Paterson N.E., Markou A. Increased motivation for self-administered cocaine after escalated cocaine intake. Neuroreport 2003, 14:2229-2232.
30. Pierce R.C., Meil W.M., Kalivas P.W. The NMDA antagonist, dizocilpine, enhances cocaine reinforcement without influencing mesoaccumbens dopamine transmission. Psychopharmacology 1997, 133:188-195.
31. Richardson N.R., Roberts D.C. Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J. Neurosci. Methods 1996, 66:1-11.
32. Scheggi S., Mangiavacchi S., Masi F., Gambarana C., Tagliamonte A., De Montis M.G. Dizocilpine infusion has a different effect in the development of morphine and cocaine sensitization: behavioral and neurochemical aspects. Neuroscience 2002, 109:267-274.
33. Schenk S., Valadez A., Worley C.M., McNamara C. Blockade of the acquisition of cocaine self-administration by the NMDA antagonist MK-801 (dizocilpine). Behav. Pharmacol. 1993, 4:652-659.
34. Schoepp D.D., Ornstein P.L., Salhoff C.R., Leander J.D. Neuroprotectant effects of LY274614, a structurally novel systemically active competitive NMDA receptor antagonist. J. Neural Transm. 1991, 85:131-143.
35. Seeman P., Ko F., Tallerico T. Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics. Mol. Psychiatry 2005, 10:877-883.
36. Substance Abuse and Mental Health Services Administration Results from 2010 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-41, HHS Publication SMA-11-4658 2011, Substance Abuse and Mental Health Services Administration, Rockville, MD.
37. Tang W., Wesley M., Freeman W.M., Liang B., Hemby S.E. Alterations in ionotropic glutamate receptor subunits during binge cocaine self-administration and withdrawal in rats. J. Neurochem. 2004, 89:1021-1033.
38. Tornatzky W., Miczek K.A. Cocaine self-administration binges: transition from behavioral and autonomic regulation toward homeostatic dysregulation in rats. Psychopharmacology 2000, 148:289-298.
39. Wee S., Specio S.E., Koob G.F. Effects of dose and session duration on cocaine self-administration in rats. J. Pharmacol. Exp. Ther. 2006, 320:1134-1143.